Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- ChecktodayChange Detected- Removed the topic 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page header.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Related topics entries for Non-alcoholic fatty liver disease and MedlinePlus Genetics on the study page.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the term 'Non-alcoholic fatty liver disease' from the page's conditions/topics and deleted the related topic link to MedlinePlus Genetics.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 and a maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.